aTyr Pharma (LIFE) Revenue & Revenue Breakdown
aTyr Pharma Revenue Highlights
Latest Revenue (Y)
$353.00K
Latest Revenue (Q)
$235.00K
Main Segment (Y)
Collaboration Revenue
aTyr Pharma Revenue by Period
aTyr Pharma Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $353.00K | -96.60% |
| 2022-12-31 | $10.39M | 100.00% |
| 2021-12-31 | - | -100.00% |
| 2020-12-31 | $10.46M | 2377.49% |
| 2019-12-31 | $422.00K | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | - |
aTyr Pharma generated $353.00K in revenue during NA 2023, up -96.60% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
aTyr Pharma Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $235.00K | -94.55% |
| 2023-12-31 | $4.32M | 1122.38% |
| 2023-09-30 | $353.00K | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | -100.00% |
| 2022-12-31 | $10.39M | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | -100.00% |
| 2020-12-31 | $2.05M | 1287.16% |
| 2020-09-30 | $148.00K | -21.69% |
| 2020-06-30 | $189.00K | -97.66% |
| 2020-03-31 | $8.06M | 5500.69% |
| 2019-12-31 | $144.00K | -21.74% |
| 2019-09-30 | $184.00K | 95.74% |
| 2019-06-30 | $94.00K | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | - |
aTyr Pharma generated $235.00K in revenue during Q1 2024, up -94.55% compared to the previous quarter, and up 2.26% compared to the same period a year ago.
aTyr Pharma Revenue Breakdown
aTyr Pharma Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 22 | Dec 20 | Dec 19 |
|---|---|---|---|
| Collaboration Revenue | $10.00M | $422.00K | - |
| License Revenue | - | $10.46M | - |
aTyr Pharma's latest annual revenue breakdown by segment (product or service), as of Dec 22: Collaboration Revenue (100.00%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Sep 23 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|
| Collaboration Revenue | $200.00K | $400.00K | $144.00K | $184.00K | $94.00K | - | - | - | - |
| License Revenue | - | - | $2.05M | $148.00K | $189.00K | $8.06M | - | - | - |
aTyr Pharma's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Collaboration Revenue (100.00%).
aTyr Pharma Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|
| License Revenue | $2.05M | $148.00K | $189.00K | $8.06M | - | - | - |
| Collaboration Revenue | - | - | - | - | $144.00K | $184.00K | $94.00K |
aTyr Pharma's latest quarterly revenue breakdown by geography, as of Dec 20: License Revenue (100.00%).
aTyr Pharma Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals | $380.79M | $88.64M |
| HOOK | HOOKIPA Pharma | $20.13M | - |
| MREO | Mereo BioPharma Group | $10.00M | - |
| LIFE | aTyr Pharma | $353.00K | $235.00K |
| XFOR | X4 Pharmaceuticals | - | $563.00K |
| PDSB | PDS Bio | - | - |
| DAWN | Day One Biopharmaceuticals | - | $20.07M |
| ABOS | Acumen Pharmaceuticals | - | - |
| INZY | Inozyme Pharma | - | - |
| TERN | Terns Pharmaceuticals | - | - |
LIFE Revenue FAQ
What is aTyr Pharma’s yearly revenue?
aTyr Pharma's yearly revenue for 2023 was $353K, representing a decrease of -96.60% compared to 2022. The company's yearly revenue for 2022 was $10.39M, representing an increase of 100.00% compared to 2021. LIFE's yearly revenue for 2021 was $0, representing a decrease of -100.00% compared to 2020.
What is aTyr Pharma’s quarterly revenue?
aTyr Pharma's quarterly revenue for Q1 2024 was $235K, a -94.55% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $4.32M, a 1122.38% increase from the previous quarter (Q3 2023), and a -58.45% decrease year-over-year (Q4 2022). LIFE's quarterly revenue for Q3 2023 was $353K, a 100.00% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).
What is aTyr Pharma’s revenue growth rate?
aTyr Pharma's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was -16.35%.
What are aTyr Pharma’s revenue streams?
aTyr Pharma's revenue streams in c 22 are Collaboration Revenue
What is aTyr Pharma’s main source of revenue?
For the fiscal year ending Dec 22, the largest source of revenue of aTyr Pharma was Collaboration Revenue. This segment made a revenue of $10M, representing 100.00% of the company's total revenue.